Mpox, previously referred to as Monkeypox, has emerged as a significant health crisis, initially affecting the Democratic Republic of Congo and spreading globally, prompting a declaration of a global emergency by the World Health Organization.
Bavarian Nordic, the sole manufacturer of the mpox vaccine, has played a crucial role in the global response by donating 40,000 doses of Imvanex to Africa, highlighting the urgent need for effective vaccines in vulnerable regions.
Despite the majority of mpox cases being mild, the disease has claimed the lives of hundreds, including children, emphasizing the importance of vaccination and public health interventions to control its spread.
Founded in 1994, Bavarian Nordic has focused on vaccine development, receiving approvals for its mpox vaccine from major health organizations while also supporting vaccine efforts in other outbreaks like Ebola.
[
Collection
]
[
|
...
]